Trial · NCT01277601
Adverse events560
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 560
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Neutropenia | Blood and lymphatic system disorders | TDF+Peg-IFN 48 Weeks (Not Retreated) | 15 | 186 | |
| other | Neutropenia | Blood and lymphatic system disorders | TDF+Peg-IFN 48 Weeks (Retreated) | 0 | 112 | |
| other | Neutropenia | Blood and lymphatic system disorders | TDF 48 Week + Peg-IFN 16 Weeks (Not Retreated) | 11 | 184 | |
| other | Neutropenia | Blood and lymphatic system disorders | TDF 48 Weeks + Peg-IFN 16 Weeks (Retreated) | 1 | 115 | |
| other | Neutropenia | Blood and lymphatic system disorders | TDF 120 Weeks | 0 | 185 | |
| other | Neutropenia | Blood and lymphatic system disorders | Peg-IFN 48 Weeks (Not Retreated) | 15 | 185 | |
| other | Neutropenia | Blood and lymphatic system disorders | Peg-IFN 48 Weeks (Retreated) | 0 | 117 | |
| other | Abdominal pain | Gastrointestinal disorders | TDF+Peg-IFN 48 Weeks (Not Retreated) | 7 | 186 | |
| other | Abdominal pain | Gastrointestinal disorders | TDF+Peg-IFN 48 Weeks (Retreated) | 1 | 112 | |
| other | Abdominal pain | Gastrointestinal disorders | TDF 48 Week + Peg-IFN 16 Weeks (Not Retreated) | 6 | 184 | |
| other | Abdominal pain | Gastrointestinal disorders | TDF 48 Weeks + Peg-IFN 16 Weeks (Retreated) | 1 | 115 | |
| other | Abdominal pain | Gastrointestinal disorders | TDF 120 Weeks | 6 | 185 | |
| other | Abdominal pain | Gastrointestinal disorders | Peg-IFN 48 Weeks (Not Retreated) | 10 | 185 | |
| other | Abdominal pain | Gastrointestinal disorders | Peg-IFN 48 Weeks (Retreated) | 1 | 117 | |
| other | Abdominal pain upper | Gastrointestinal disorders | TDF+Peg-IFN 48 Weeks (Not Retreated) | 11 | 186 | |
| other | Abdominal pain upper | Gastrointestinal disorders | TDF+Peg-IFN 48 Weeks (Retreated) | 2 | 112 | |
| other | Abdominal pain upper | Gastrointestinal disorders | TDF 48 Week + Peg-IFN 16 Weeks (Not Retreated) | 7 | 184 | |
| other | Abdominal pain upper | Gastrointestinal disorders | TDF 48 Weeks + Peg-IFN 16 Weeks (Retreated) | 0 | 115 | |
| other | Abdominal pain upper | Gastrointestinal disorders | TDF 120 Weeks | 7 | 185 | |
| other | Abdominal pain upper | Gastrointestinal disorders | Peg-IFN 48 Weeks (Not Retreated) | 6 | 185 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01277601/events